Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 246

1.

MiR-218 and miR-100 polymorphisms as markers of irinotecan-based chemotherapy response in metastatic colorectal cancer.

Lampropoulou DI, Aravantinos G, Laschos K, Theodosopoulos T, Papadimitriou C, Gazouli M.

Int J Colorectal Dis. 2019 Oct 9. doi: 10.1007/s00384-019-03401-3. [Epub ahead of print]

PMID:
31598748
2.

Novel potential biomarkers for the diagnosis and monitoring of patients with ulcerative colitis.

Kourkoulis P, Kapizioni C, Michalopoulos G, Andreou NP, Papaconstantinou I, Karamanolis G, Gazouli M.

Eur J Gastroenterol Hepatol. 2019 Oct;31(10):1173-1183. doi: 10.1097/MEG.0000000000001490.

PMID:
31498278
3.

Association Between hsa-miR-30e Polymorphisms and Sporadic Primary Hyperparathyroidism Risk.

Mizamtsidi M, Nastos K, Palazzo F, Constantinides V, Dina R, Farenden M, Mastorakos G, Vassiliou I, Gazouli M.

In Vivo. 2019 Jul-Aug;33(4):1263-1269. doi: 10.21873/invivo.11598.

4.

Differential genetic and functional background in inflammatory bowel disease phenotypes of a Greek population: a systems bioinformatics approach.

Gazouli M, Dovrolis N, Franke A, Spyrou GM, Sechi LA, Kolios G.

Gut Pathog. 2019 Jun 15;11:31. doi: 10.1186/s13099-019-0312-y. eCollection 2019.

5.

Evaluation of MET T1010I and MET rs40239 single-nucleotide polymorphisms in triple-negative breast cancer: a case-control study.

Kalapanida D, Zagouri F, Gazouli M, Tsiakou A, Zografos E, Dimitrakakis C, Marinopoulos S, Giannos A, Sergentanis TN, Kastritis E, Terpos E, Dimopoulos MA.

Onco Targets Ther. 2019 May 28;12:4195-4202. doi: 10.2147/OTT.S189329. eCollection 2019.

6.

Methylation profile of genes involved in inflammation, in the blood from pregnancies with maternal preeclampsia due to untreated gestational diabetes mellitus.

Halvatsiotis P, Tsokaki T, Chrelias C, Kassanos D, Domali E, Gazouli M, Dimitriadis G, Kalantaridou S.

Hormones (Athens). 2019 Jun;18(2):173-178. doi: 10.1007/s42000-019-00111-x. Epub 2019 Jun 1.

PMID:
31154656
7.

Incorporation of PEGylated δ-decalactone into lipid bilayers: thermodynamic study and chimeric liposomes development.

Pippa N, Skouras A, Naziris N, Biondo F, Tiboni M, Katifelis H, Gazouli M, Demetzos C, Casettari L.

J Liposome Res. 2019 Jun 14:1-9. doi: 10.1080/08982104.2019.1625377. [Epub ahead of print]

PMID:
31146618
8.

Genetic polymorphisms associated with the prevalence of retinal vein occlusion in a Greek population.

Christodoulou A, Bagli E, Gazouli M, Moschos MM, Kitsos G.

Int Ophthalmol. 2019 May 7. doi: 10.1007/s10792-019-01113-9. [Epub ahead of print]

PMID:
31065901
9.

Polymorphisms of the BARX1 and ADAMTS17 Locus Genes in Individuals With Gastroesophageal Reflux Disease.

Argyrou A, Legaki E, Koutserimpas C, Gazouli M, Papaconstantinou I, Gkiokas G, Karamanolis G.

J Neurogastroenterol Motil. 2019 Jul 1;25(3):436-441. doi: 10.5056/jnm18183.

10.

Long non-coding RNA polymorphisms and prediction of response to chemotherapy based on irinotecan in patients with metastatic colorectal cancer.

Lampropoulou DI, Aravantinos G, Katifelis H, Lazaris F, Laschos K, Theodosopoulos T, Papadimitriou C, Gazouli M.

Cancer Biomark. 2019;25(2):213-221. doi: 10.3233/CBM-182383.

PMID:
31045514
11.

DAB2IP Expression in Abdominal Aortic Aneurysm: EZH2 and mir-363-3p as Potential Mediators.

Legaki E, Klonaris C, Athanasiadis D, Patelis N, Sioziou A, Liakakos T, Gazouli M.

In Vivo. 2019 May-Jun;33(3):737-742. doi: 10.21873/invivo.11533.

12.

Prognostic significance of miR-34 rs4938723 T > C polymorphism in triple negative breast cancer patients.

Tsiakou A, Zagouri F, Zografos E, Samelis G, Gazouli M, Kalapanida D, Giannos A, Marinopoulos S, Dimitrakakis K, Lazaris C A, Rigopoulos D, Zografos G.

Clin Biochem. 2019 Jun;68:9-14. doi: 10.1016/j.clinbiochem.2019.03.009. Epub 2019 Mar 29.

PMID:
30935968
13.

Serum Proteomic Signatures of Male Breast Cancer.

Zografos E, Anagnostopoulos AK, Papadopoulou A, Legaki E, Zagouri F, Marinos E, Tsangaris GT, Gazouli M.

Cancer Genomics Proteomics. 2019 Mar-Apr;16(2):129-137. doi: 10.21873/cgp.20118.

14.

Contribution of ghrelin to functional gastrointestinal disorders' pathogenesis.

Koutouratsas T, Kalli T, Karamanolis G, Gazouli M.

World J Gastroenterol. 2019 Feb 7;25(5):539-551. doi: 10.3748/wjg.v25.i5.539. Review.

15.

Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma.

Obazee O, Archibugi L, Andriulli A, Soucek P, Małecka-Panas E, Ivanauskas A, Johnson T, Gazouli M, Pausch T, Lawlor RT, Cavestro GM, Milanetto AC, Di Leo M, Pasquali C, Hegyi P, Szentesi A, Radu CE, Gheorghe C, Theodoropoulos GE, Bergmann F, Brenner H, Vodickova L, Katzke V, Campa D, Strobel O, Kaiser J, Pezzilli R, Federici F, Mohelnikova-Duchonova B, Boggi U, Lemstrova R, Johansen JS, Bojesen SE, Chen I, Jensen BV, Capurso G, Pazienza V, Dervenis C, Sperti C, Mambrini A, Hackert T, Kaaks R, Basso D, Talar-Wojnarowska R, Maiello E, Izbicki JR, Cuk K, Saum KU, Cantore M, Kupcinskas J, Palmieri O, Delle Fave G, Landi S, Salvia R, Fogar P, Vashist YK, Scarpa A, Vodicka P, Tjaden C, Iskierka-Jazdzewska E, Canzian F.

Int J Cancer. 2019 Aug 1;145(3):686-693. doi: 10.1002/ijc.32127. Epub 2019 Feb 7.

PMID:
30672594
16.

Evaluation of pre-mir-34a rs72631823 single nucleotide polymorphism in triple negative breast cancer: A case-control study.

Kalapanida D, Zagouri F, Gazouli M, Zografos E, Dimitrakakis C, Marinopoulos S, Giannos A, Sergentanis TN, Kastritis E, Terpos E, Dimopoulos MA.

Oncotarget. 2018 Dec 11;9(97):36906-36913. doi: 10.18632/oncotarget.26385. eCollection 2018 Dec 11.

17.

Infliximab trough levels are decreasing over time in patients with inflammatory bowel disease on maintenance treatment with infliximab.

Orfanoudaki E, Gazouli M, Foteinogiannopoulou K, Theodoraki E, Legaki E, Romanos I, Mouzas I, Koutroubakis IE.

Eur J Gastroenterol Hepatol. 2019 Feb;31(2):187-191. doi: 10.1097/MEG.0000000000001332.

PMID:
30543573
18.

Association between genetic polymorphisms in long non-coding RNAs and pancreatic cancer risk.

Moschovis D, Vasilaki E, Tzouvala M, Karamanolis G, Katifelis H, Legaki E, Vezakis A, Aravantinos G, Gazouli M.

Cancer Biomark. 2019;24(1):117-123. doi: 10.3233/CBM-181959.

PMID:
30475759
19.

Ag/Au bimetallic nanoparticles induce apoptosis in human cancer cell lines via P53, CASPASE-3 and BAX/BCL-2 pathways.

Katifelis H, Lyberopoulou A, Mukha I, Vityuk N, Grodzyuk G, Theodoropoulos GE, Efstathopoulos EP, Gazouli M.

Artif Cells Nanomed Biotechnol. 2018;46(sup3):S389-S398. doi: 10.1080/21691401.2018.1495645. Epub 2018 Oct 29.

PMID:
30371113
20.

Risk factors for gastroesophageal reflux disease and analysis of genetic contributors.

Argyrou A, Legaki E, Koutserimpas C, Gazouli M, Papaconstantinou I, Gkiokas G, Karamanolis G.

World J Clin Cases. 2018 Aug 16;6(8):176-182. doi: 10.12998/wjcc.v6.i8.176. Review.

21.

"Extracellular matrix remodelling in the liver of rats subjected to dietary choline deprivation and/or thioacetamide administration".

Al-Humadi H, Alhumadi A, Al-Saigh R, Strilakou A, Lazaris AC, Gazouli M, Liapi C.

Clin Exp Pharmacol Physiol. 2018 Dec;45(12):1245-1256. doi: 10.1111/1440-1681.13013. Epub 2018 Aug 22.

PMID:
30019784
22.

Successful use of adipose-derived mesenchymal stem cells to correct a male breast affected by Poland Syndrome: a case report.

Christopoulos A, Ligoudistianou C, Bethanis P, Gazouli M.

J Surg Case Rep. 2018 Jul 9;2018(7):rjy151. doi: 10.1093/jscr/rjy151. eCollection 2018 Jul.

23.

Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms.

Obazee O, Capurso G, Tavano F, Archibugi L, De Bonis A, Greenhalf W, Key T, Pasquali C, Milanetto AC, Hackert T, Fogar P, Lico V, Dervenis C, Lawlor RT, Landoni L, Gazouli M, Zambon CF, Funel N, Strobel O, Jamroziak K, Cantu C, Malecka-Panas E, Landi S, Neoptolemos JP, Basso D, Talar-Wojnarowska R, Rinzivillo M, Andriulli A, Canzian F, Campa D.

Carcinogenesis. 2018 Jul 3;39(7):969. doi: 10.1093/carcin/bgy067. No abstract available.

PMID:
29868886
24.

Interleukin 15 concentrations in follicular fluid and their effect on oocyte maturation in subfertile women undergoing intracytoplasmic sperm injection.

Spanou S, Kalogiannis D, Zapanti E, Gazouli M, Sfontouris IA, Siristatidis C, Mastorakos G.

J Assist Reprod Genet. 2018 Jun;35(6):1019-1025. doi: 10.1007/s10815-018-1170-0. Epub 2018 Apr 4.

25.

Correlation of polymorphisms in long non-coding RNAs with the pathogenesis of inflammatory bowel diseases.

Zacharopoulou E, Ioakeim S, Tzouvala M, Karamanolis G, Vezakis A, Gazouli M.

Dig Liver Dis. 2018 Jun;50(6):624-626. doi: 10.1016/j.dld.2018.03.008. Epub 2018 Mar 13. No abstract available.

PMID:
29610021
26.

Expression of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Human Epicardial and Intramyocardial Coronary Arteries of Male Patients Undergoing Coronary Artery Bypass Grafting.

Synetos A, Karanasos A, Spyropoulos S, Gazouli M, Latsios G, Toutouzas K, Perrea D, Tousoulis D, Chloroyiannis IA.

Cardiology. 2018;139(4):203-207. doi: 10.1159/000486634. Epub 2018 Feb 15.

PMID:
29448251
27.

Gallium-68 Labeled Iron Oxide Nanoparticles Coated with 2,3-Dicarboxypropane-1,1-diphosphonic Acid as a Potential PET/MR Imaging Agent: A Proof-of-Concept Study.

Karageorgou MA, Vranješ-Djurić S, Radović M, Lyberopoulou A, Antić B, Rouchota M, Gazouli M, Loudos G, Xanthopoulos S, Sideratou Z, Stamopoulos D, Bouziotis P, Tsoukalas C.

Contrast Media Mol Imaging. 2017 Dec 28;2017:6951240. doi: 10.1155/2017/6951240. eCollection 2017.

28.

Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer.

Klein AP, Wolpin BM, Risch HA, Stolzenberg-Solomon RZ, Mocci E, Zhang M, Canzian F, Childs EJ, Hoskins JW, Jermusyk A, Zhong J, Chen F, Albanes D, Andreotti G, Arslan AA, Babic A, Bamlet WR, Beane-Freeman L, Berndt SI, Blackford A, Borges M, Borgida A, Bracci PM, Brais L, Brennan P, Brenner H, Bueno-de-Mesquita B, Buring J, Campa D, Capurso G, Cavestro GM, Chaffee KG, Chung CC, Cleary S, Cotterchio M, Dijk F, Duell EJ, Foretova L, Fuchs C, Funel N, Gallinger S, M Gaziano JM, Gazouli M, Giles GG, Giovannucci E, Goggins M, Goodman GE, Goodman PJ, Hackert T, Haiman C, Hartge P, Hasan M, Hegyi P, Helzlsouer KJ, Herman J, Holcatova I, Holly EA, Hoover R, Hung RJ, Jacobs EJ, Jamroziak K, Janout V, Kaaks R, Khaw KT, Klein EA, Kogevinas M, Kooperberg C, Kulke MH, Kupcinskas J, Kurtz RJ, Laheru D, Landi S, Lawlor RT, Lee IM, LeMarchand L, Lu L, Malats N, Mambrini A, Mannisto S, Milne RL, Mohelníková-Duchoňová B, Neale RE, Neoptolemos JP, Oberg AL, Olson SH, Orlow I, Pasquali C, Patel AV, Peters U, Pezzilli R, Porta M, Real FX, Rothman N, Scelo G, Sesso HD, Severi G, Shu XO, Silverman D, Smith JP, Soucek P, Sund M, Talar-Wojnarowska R, Tavano F, Thornquist MD, Tobias GS, Van Den Eeden SK, Vashist Y, Visvanathan K, Vodicka P, Wactawski-Wende J, Wang Z, Wentzensen N, White E, Yu H, Yu K, Zeleniuch-Jacquotte A, Zheng W, Kraft P, Li D, Chanock S, Obazee O, Petersen GM, Amundadottir LT.

Nat Commun. 2018 Feb 8;9(1):556. doi: 10.1038/s41467-018-02942-5.

29.

Diagnosis, management, histology and genetics of sporadic primary hyperparathyroidism: old knowledge with new tricks.

Mizamtsidi M, Nastos C, Mastorakos G, Dina R, Vassiliou I, Gazouli M, Palazzo F.

Endocr Connect. 2018 Feb;7(2):R56-R68. doi: 10.1530/EC-17-0283. Epub 2018 Jan 12. Review.

30.

Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms.

Obazee O, Capurso G, Tavano F, Archibugi L, De Bonis A, Greenhalf W, Key T, Pasquali C, Milanetto AC, Hackert T, Fogar P, Liço V, Dervenis C, Lawlor RT, Landoni L, Gazouli M, Zambon CF, Funel N, Strobel O, Jamroziak K, Cantù C, Malecka-Panas E, Landi S, Neoptolemos JP, Basso D, Talar-Wojnarowska R, Rinzivillo M, Andriulli A, Canzian F, Campa D.

Carcinogenesis. 2018 Mar 8;39(3):360-367. doi: 10.1093/carcin/bgx150. Erratum in: Carcinogenesis. 2018 Jul 3;39(7):969.

PMID:
29309705
31.

Correction: Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease.

Williams AD, Korolkova OY, Sakwe AM, Geiger TM, James SD, Muldoon RL, Herline AJ, Goodwin JS, Izban MG, Washington MK, Smoot DT, Ballard BR, Gazouli M, M'Koma AE.

PLoS One. 2017 Dec 6;12(12):e0189551. doi: 10.1371/journal.pone.0189551. eCollection 2017.

32.

Association of miR-146 rs2910164, miR-196a rs11614913, miR-221 rs113054794 and miR-224 rs188519172 polymorphisms with anti-TNF treatment response in a Greek population with Crohn's disease.

Papaconstantinou I, Kapizioni C, Legaki E, Xourgia E, Karamanolis G, Gklavas A, Gazouli M.

World J Gastrointest Pharmacol Ther. 2017 Nov 6;8(4):193-200. doi: 10.4292/wjgpt.v8.i4.193.

33.

Long non-coding RNA in pancreatic adenocarcinoma and pancreatic neuroendocrine tumors.

Moschovis D, Gazouli M, Tzouvala M, Vezakis A, Karamanolis G.

Ann Gastroenterol. 2017;30(6):622-628. doi: 10.20524/aog.2017.0185. Epub 2017 Aug 4. Review.

34.

Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation.

Campa D, Pastore M, Capurso G, Hackert T, Di Leo M, Izbicki JR, Khaw KT, Gioffreda D, Kupcinskas J, Pasquali C, Macinga P, Kaaks R, Stigliano S, Peeters PH, Key TJ, Talar-Wojnarowska R, Vodicka P, Valente R, Vashist YK, Salvia R, Papaconstantinou I, Shimizu Y, Valsuani C, Zambon CF, Gazouli M, Valantiene I, Niesen W, Mohelnikova-Duchonova B, Hara K, Soucek P, Malecka-Panas E, Bueno-de-Mesquita HBA, Johnson T, Brenner H, Tavano F, Fogar P, Ito H, Sperti C, Butterbach K, Latiano A, Andriulli A, Cavestro GM, Busch ORC, Dijk F, Greenhalf W, Matsuo K, Lombardo C, Strobel O, König AK, Cuk K, Strothmann H, Katzke V, Cantore M, Mambrini A, Oliverius M, Pezzilli R, Landi S, Canzian F.

Int J Cancer. 2018 Jan 15;142(2):290-296. doi: 10.1002/ijc.31047. Epub 2017 Oct 16.

35.

BAX and BCL2 Gene Polymorphisms in Rhegmatogenous Retinal Detachment.

Moschos MM, Chatziralli I, Brouzas D, Gazouli M.

Ophthalmic Res. 2017;58(4):227-230. doi: 10.1159/000479700. Epub 2017 Sep 7.

PMID:
28877516
36.

The contribution of long non-coding RNAs in Inflammatory Bowel Diseases.

Zacharopoulou E, Gazouli M, Tzouvala M, Vezakis A, Karamanolis G.

Dig Liver Dis. 2017 Oct;49(10):1067-1072. doi: 10.1016/j.dld.2017.08.003. Epub 2017 Aug 9. Review.

PMID:
28869157
37.

Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease.

Williams AD, Korolkova OY, Sakwe AM, Geiger TM, James SD, Muldoon RL, Herline AJ, Goodwin JS, Izban MG, Washington MK, Smoot DT, Ballard BR, Gazouli M, M'Koma AE.

PLoS One. 2017 Aug 17;12(8):e0179710. doi: 10.1371/journal.pone.0179710. eCollection 2017. Erratum in: PLoS One. 2017 Dec 6;12 (12 ):e0189551.

38.

Identification of serum proteome signature of irritable bowel syndrome: Potential utility of the tool for early diagnosis and patient's stratification.

Tsigaridas A, Anagnostopoulos AK, Papadopoulou A, Ioakeim S, Vaiopoulou A, Papanikolaou IS, Viazis N, Karamanolis G, Mantzaris GJ, Tsangaris GT, Gazouli M.

J Proteomics. 2018 Sep 30;188:167-172. doi: 10.1016/j.jprot.2017.07.019. Epub 2017 Jul 28.

PMID:
28757466
39.

Prognostic and predictive factors in patients with metastatic or recurrent cervical cancer treated with platinum-based chemotherapy.

Karageorgopoulou S, Kostakis ID, Gazouli M, Markaki S, Papadimitriou M, Bournakis E, Dimopoulos MA, Papadimitriou CA.

BMC Cancer. 2017 Jun 28;17(1):451. doi: 10.1186/s12885-017-3435-x.

40.

Molecular Proteomic Characterization of a Pediatric Medulloblastoma Xenograft.

Tsangaris GT, Dimas K, Malamou A, Katsafadou A, Papathanasiou C, Stravopodis DJ, Vorgias CE, Gazouli M, Anagnostopoulos AK.

Cancer Genomics Proteomics. 2017 Jul-Aug;14(4):267-275.

41.

Abnormal DNA methylation as a cell-free circulating DNA biomarker for colorectal cancer detection: A review of literature.

Galanopoulos M, Tsoukalas N, Papanikolaou IS, Tolia M, Gazouli M, Mantzaris GJ.

World J Gastrointest Oncol. 2017 Apr 15;9(4):142-152. doi: 10.4251/wjgo.v9.i4.142. Review.

42.

Receptor of Advanced Glycation End Products Gene Polymorphism and Primary Open-Angle Glaucoma.

Moschos MM, Chatziralli I, Sioziou A, Gazouli M.

Ophthalmic Res. 2017;58(2):81-84. doi: 10.1159/000464448. Epub 2017 Apr 12.

PMID:
28399536
43.

Proteomics and irritable bowel syndrome.

Tsigaridas A, Papanikolaou IS, Vaiopoulou A, Anagnostopoulos AK, Viazis N, Karamanolis G, Karamanolis DG, Tsangaris GT, Mantzaris GJ, Gazouli M.

Expert Rev Proteomics. 2017 May;14(5):461-468. doi: 10.1080/14789450.2017.1317600. Epub 2017 Apr 17. Review.

PMID:
28395553
44.

The Q192R polymorphism of the paraoxonase-1 (PON1) gene is associated with susceptibility to gestational diabetes mellitus in the Greek population.

Pappa KI, Gazouli M, Anastasiou E, Loutradis D, Anagnou NP.

Gynecol Endocrinol. 2017 Aug;33(8):617-620. doi: 10.1080/09513590.2017.1302419. Epub 2017 Mar 28.

PMID:
28347194
45.

Identification of Methylation Profiles of Cancer-related Genes in Circulating Tumor Cells Population.

Lyberopoulou A, Galanopoulos M, Aravantinos G, Theodoropoulos GE, Marinos E, Efstathopoulos EP, Gazouli M.

Anticancer Res. 2017 Mar;37(3):1105-1112.

PMID:
28314271
46.

SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival.

Mohelnikova-Duchonova B, Strouhal O, Hughes DJ, Holcatova I, Oliverius M, Kala Z, Campa D, Rizzato C, Canzian F, Pezzilli R, Talar-Wojnarowska R, Malecka-Panas E, Sperti C, Federico Zambon C, Pedrazzoli S, Fogar P, Milanetto AC, Capurso G, Delle Fave G, Valente R, Gazouli M, Malleo G, Teresa Lawlor R, Strobel O, Hackert T, Giese N, Vodicka P, Vodickova L, Landi S, Tavano F, Gioffreda D, Piepoli A, Pazienza V, Mambrini A, Pedata M, Cantore M, Bambi F, Ermini S, Funel N, Lemstrova R, Soucek P.

Sci Rep. 2017 Mar 8;7:43812. doi: 10.1038/srep43812.

47.

Comparative Study of Mutations in Single Nucleotide Polymorphism Loci of KRAS and BRAF Genes in Patients Who Underwent Screening Colonoscopy, With and Without Premalignant Intestinal Polyps.

Galanopoulos M, Papanikolaou IS, Zografos E, Viazis N, Papatheodoridis G, Karamanolis D, Marinos E, Mantzaris GJ, Gazouli M.

Anticancer Res. 2017 Feb;37(2):651-657.

PMID:
28179313
48.

Intestinal Bacteria Composition and Translocation of Bacteria in Inflammatory Bowel Disease.

Vrakas S, Mountzouris KC, Michalopoulos G, Karamanolis G, Papatheodoridis G, Tzathas C, Gazouli M.

PLoS One. 2017 Jan 18;12(1):e0170034. doi: 10.1371/journal.pone.0170034. eCollection 2017.

49.

Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors.

Campa D, Capurso G, Pastore M, Talar-Wojnarowska R, Milanetto AC, Landoni L, Maiello E, Lawlor RT, Malecka-Panas E, Funel N, Gazouli M, De Bonis A, Klüter H, Rinzivillo M, Delle Fave G, Hackert T, Landi S, Bugert P, Bambi F, Archibugi L, Scarpa A, Katzke V, Dervenis C, Liço V, Furlanello S, Strobel O, Tavano F, Basso D, Kaaks R, Pasquali C, Gentiluomo M, Rizzato C, Canzian F.

Sci Rep. 2016 Dec 23;6:39565. doi: 10.1038/srep39565.

50.

Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21.

Zhang M, Wang Z, Obazee O, Jia J, Childs EJ, Hoskins J, Figlioli G, Mocci E, Collins I, Chung CC, Hautman C, Arslan AA, Beane-Freeman L, Bracci PM, Buring J, Duell EJ, Gallinger S, Giles GG, Goodman GE, Goodman PJ, Kamineni A, Kolonel LN, Kulke MH, Malats N, Olson SH, Sesso HD, Visvanathan K, White E, Zheng W, Abnet CC, Albanes D, Andreotti G, Brais L, Bueno-de-Mesquita HB, Basso D, Berndt SI, Boutron-Ruault MC, Bijlsma MF, Brenner H, Burdette L, Campa D, Caporaso NE, Capurso G, Cavestro GM, Cotterchio M, Costello E, Elena J, Boggi U, Gaziano JM, Gazouli M, Giovannucci EL, Goggins M, Gross M, Haiman CA, Hassan M, Helzlsouer KJ, Hu N, Hunter DJ, Iskierka-Jazdzewska E, Jenab M, Kaaks R, Key TJ, Khaw KT, Klein EA, Kogevinas M, Krogh V, Kupcinskas J, Kurtz RC, Landi MT, Landi S, Le Marchand L, Mambrini A, Mannisto S, Milne RL, Neale RE, Oberg AL, Panico S, Patel AV, Peeters PH, Peters U, Pezzilli R, Porta M, Purdue M, Quiros JR, Riboli E, Rothman N, Scarpa A, Scelo G, Shu XO, Silverman DT, Soucek P, Strobel O, Sund M, Małecka-Panas E, Taylor PR, Tavano F, Travis RC, Thornquist M, Tjønneland A, Tobias GS, Trichopoulos D, Vashist Y, Vodicka P, Wactawski-Wende J, Wentzensen N, Yu H, Yu K, Zeleniuch-Jacquotte A, Kooperberg C, Risch HA, Jacobs EJ, Li D, Fuchs C, Hoover R, Hartge P, Chanock SJ, Petersen GM, Stolzenberg-Solomon RS, Wolpin BM, Kraft P, Klein AP, Canzian F, Amundadottir LT.

Oncotarget. 2016 Oct 11;7(41):66328-66343. doi: 10.18632/oncotarget.11041.

Supplemental Content

Loading ...
Support Center